Delivery Order SPE2DB22D1103-SPE2DB23FTAK1
- Not listed
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, by the prime contractor Amerisourcebergen Drug Corp. The $29,323.35 contract is a firm fixed-price delivery order with a completion date of May 27, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products. The Delivery Order, valued at $10,633.32, has a firm fixed price and an ultimate completion date of April 25, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Medical Supply Chain, a subcomponent of the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $43,318.16. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL pharmaceutical products to the Defense Logistics Agency (DLA). The $5,486.46 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceuticals and medical supplies to the U.S. government. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. This...
- This federal contract award is for the delivery of Humira(CF) Pen 40 mg/0.4 mls, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical program. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $17,564.47 and an ultimate completion date of November 2, 2023. This is a delivery order contract with a firm fixed-price pricing...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $27,032.35 and an ultimate completion date of November 9, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not designated as a set-aside contract....
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The $3,928.62 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has an ultimate completion date of March 8, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals to the Defense Logistics Agency (DLA). The $3,523.38 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award has an ultimate completion date of January 2, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- The federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $12,372.64 and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 15, 2024. The contract has an ultimate completion date of August 16, 2024 and is a Firm Fixed Price Delivery Order. The contract is not a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Humira (CF) Pen 40 mg/0.4 mL to the Defense Logistics Agency (DLA). The contract, valued at $7,580.06, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on May 20, 2024. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 21, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB23FTAK1Delivery Order
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $12,288.36. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 28, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/27/23 |